RESEARCH TRIANGLE PARK, NC – A new study released by Cutting Edge Information finds that many pharmaceutical companies are revamping their medical publication structures in response to regulatory demands. The report examines the medical publication activities at a wide range of companies in various therapeutic areas.

As companies draw thicker lines between their clinical and commercial departments, the medical publications structure is inevitably affected. Although the function has traditionally been a part of the marketing department, many companies are responding to FDA scrutiny by changing this structure. Rather than have medical publications teams report to marketing, many companies now house medical publications under medical affairs.

“We are seeing a definite shift in the way pharma companies manage their medical publications,” says Amanda Zuniga, senior research analyst at Cutting Edge Information. According to Zuniga, medical publications departments are becoming more closely aligned with the research and clinical side of businesses than with the commercial side. The study results agree – of those companies that have a dedicated medical publications department, 78% house that department under medical affairs.

Pharmaceutical Medical Publications: Market Preparation & Strategic Support, was designed to explore pharmaceutical companies’ medical publications structures, strategies and processes. The study delves into the resource support and funding that various medical publication departments and teams benefit from. In addition, through this report, readers will be exposed to some of the industry’s best medical publication practices and should be better positioned to streamline their own strategies and processes by benchmarking their efforts against those of top-leading companies.

Visit the report site to download a summary of Pharmaceutical Medical Publications.

<-- Back to the News Page

<-- Back to the Cutting Edge Information home page